KRAS wild-type lung cancer: a moving target in an era of genotype migration

J Clin Oncol. 2012 Sep 20;30(27):3322-4. doi: 10.1200/JCO.2012.43.2740. Epub 2012 Aug 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*
  • Quinazolinones / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Quinazolinones
  • dacomitinib
  • Erlotinib Hydrochloride